Thiazolopyrimidine modulators as immunosuppressive agents
US-9221822-B2 · Dec 29, 2015 · US
US8993755B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993755-B2 |
| Application number | US-201414158595-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 17, 2014 |
| Priority date | Jun 29, 2007 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application includes a compound of Formula I or II: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.
Opening claim text (preview).
What is claimed: 1. A compound represented by Formula Ia: or a pharmaceutically acceptable salt thereof, wherein: R 1 is selected from the group consisting of R 2 is H; -L 3 -R 3 is —OCH 2 CH 2 OCH 3 , —OCH 2 CH 2 CH 3 , —OCH 2 CH 2 CH 2 CH 3…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.